An economic model comparing linezolid and vancomycin for treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

被引：0

作者：

Patel, Dipen A. ^{[1
]}

Shorr, Andrew F. ^{[2
]}

Chastre, Jean ^{[3
]}

Niederman, Michael ^{[4
]}

Simor, Andrew ^{[5
]}

Stephens, Jennifer M. ^{[1
]}

Bhatt, Gaurang ^{[6
]}

Charbonneau, Claudie ^{[7
]}

Gao, Xin ^{[1
]}

Nathwani, Dilip ^{[8
]}

机构：

[1] Pharmerit Int, Bethesda, MD USA

[2] Washington Hosp Ctr, Washington, DC 20010 USA

[3] Hop La Pitie Salpetriere, Paris, France

[4] Winthrop Univ Hosp, Mineola, NY 11501 USA

[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada

[6] Pfizer Inc, Collegeville, PA USA

[7] Pfizer PIO, Paris, France

[8] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland

来源：

PHARMACOTHERAPY | 2013年 / 33卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

107

引用

页码：E214 / E214

页数：1

共 50 条

[41] Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis in an experimental rabbit model
Calik, Sebnem
Turhan, Tuncer
Yurtseven, Taskin
Sipahi, Oguz Resat
Buke, Cagri
MEDICAL SCIENCE MONITOR, 2012, 18 (11): : SC5 - SC8
[42] Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
Kato, Hideo
Hagihara, Mao
Asai, Nobuhiro
Shibata, Yuichi
Koizumi, Yusuke
Yamagishi, Yuka
Mikamo, Hiroshige
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 : 98 - 105
[43] Linezolid vs vancomycin -: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
Wunderink, RG
Rello, J
Cammarata, SK
Croos-Dabrera, RV
Kollef, MH
CHEST, 2003, 124 (05) : 1789 - 1797
[44] Cost-effectiveness of linezolid vs. vancomycin in nosocomial pneumonia due to suspected methicillin-resistant Staphylococcus aureus in France
De Cock, E.
Timsit, J. F.
Carlet, J.
Leroy, O.
Wolff, M.
Levrat, F.
VALUE IN HEALTH, 2007, 10 (06) : A439 - A439
[45] Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid
Hamilton, Leslie A.
Wood, G. Christopher
Magnotti, Louis J.
Croce, Martin A.
Martin, Julie B.
Swanson, Joseph M.
Boucher, Bradley A.
Fabian, Timothy C.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (06): : 1478 - 1483
[46] Comparative Study on the Antibacterial Activity and Efficacy of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus Rat Pneumonia Model
Hou, Sicong
Zhou, Li
Wu, Hongying
JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (01) : 110 - 114
[47] Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs
Martinez-Olondris, Pilar
Rigol, Montserrat
Soy, Dolors
Guerrero, Laura
Agusti, Carlos
Quera, Maria Angels
Bassi, Gianluigi Li
Esperatti, Mariano
Luque, Nestor
Liapikou, Manto
Filella, Xavier
Marco, Francesc
de la Bellacasa, Jordi Puig
Torres, Antoni
CRITICAL CARE MEDICINE, 2012, 40 (01) : 162 - 168
[48] Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan
Kohno, S.
Yamaguchi, K.
Aikawa, N.
Sumiyama, Y.
Odagiri, S.
Aoki, N.
Niki, Y.
Watanabe, S.
Furue, M.
Ito, T.
Croos-Dabrera, R.
Tack, K. J.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1361 - 1369
[49] Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumonia
Nagaoka, Kentaro
Yanagihara, Katsunori
Harada, Yosuke
Yamada, Koichi
Migiyama, Yohei
Morinaga, Yoshitomo
Izumikawa, Koichi
Kakeya, Hiroshi
Yamamoto, Yoshihiro
Nishimura, Masaharu
Kohno, Shigeru
RESPIROLOGY, 2014, 19 (04) : 556 - 562
[50] Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus
Maclayton, Darego O.
Hall, Ronald G., II
ANNALS OF PHARMACOTHERAPY, 2007, 41 (02) : 235 - 244

← 1 2 3 4 5 →